Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2009

Feb 6, 2009

29777_dirs_2009-02-06_c6759733-4326-4208-b424-9fb3fd82fe0e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2009-02-04

Reporting Person: Szela Mary T (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-02-04 Common shares without par value M 3445 $45.4488 Acquired 100096 Direct
2009-02-04 Common shares without par value F 2996 $56.98 Disposed 97100 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-02-04 Option (right to buy) $45.4488 M 3445 Disposed 2011-02-08 Common Shares (3445) Direct
2008-02-04 Option (right to buy) $56.98 A 2996 Acquired 2011-02-08 Common Shares (2996) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 8068 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 4, 2009.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.